KwaZulu-Natal, 12 September 2022 – SAHPRA is planning on visiting universities that offer studies relating to pharmacy and medicines. These visits will create an awareness about SAHPRA to students. Its mandate and its roles and responsibilities include educating the students about the Authority’s programmes. There will...
Pretoria, 26 August 2022 – Representatives of the GHPP-PharmTrain Project, part of Germany’s Federal Ministry of Health and located at the Federal Institute for Drugs and Medical Devices (BfArM), visited the South African Health Products Authority (SAHPRA) to discuss future collaboration in capacity-building. The project...
Pexels via Pixabay...
Johannesburg, 06 August 2022 - The South African Health Products Regulatory Authority (SAHPRA) was invited to speak at this year’s South African Association of Pharmacists in Industry (SAAPI) Conference during 03-05 August 2022 sharing vital information across core functional areas of the organisation. SAHPRA was...
04 August 2022 On 31 March 2021, SAHPRA approved the use of the COVID-19 Vaccine Janssen for individuals 18 years of age and older as a single primary vaccination dose. COVID-19 Vaccine Janssen was later approved as a single booster dose given at least two months...
Pretoria, 22 July 2022 - SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, clinched a Management Award at last night's 24th National Science and Technology Forum (NSTF) Awards, that recognises outstanding contributions to science, engineering and technology (SET), and innovation. According to NSTF, Dr Semete-Makokotlela earned her accolade as...
21 July 2022 Johannesburg – The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA) delivered an informative Compliance Workshop at the National Institute of Communicable Diseases (NICD) on Thursday, 21 July 2022. Radiation Control Manager, Kgomotso Tlhapi, led the workshop during the first...
Embargo: Immediate release Pretoria, 20 July 2022 – The South African Health Products Regulatory Authority (SAHPRA) has noted the numerous media articles on the statement made by Minister Sisulu, having secured medicine for the late Jessie Duarte. To this effect, SAHPRA is looking into the reports...
19 July 2022 Johannesburg – The South African Health Products Regulatory Authority (SAHPRA) and the UK’s Department for International Trade (DIT) signed a Memorandum of Understanding (MOU) today, in Sandton. The key objective of the MOU is to demonstrate the countries’ intentions to collaborate in good faith,...
28 June 2022 Pretoria – The South African Health Products Regulatory Authority (SAHPRA) initially signed a Memorandum of Understanding (MOU) with the South African National Accreditation System (SANAS) in 2017 and this will now be extended in 2022. This MOU will now also incorporate the following activities...
